Journal
HEMATOLOGICAL ONCOLOGY
Volume 34, Issue 3, Pages 165-170Publisher
WILEY-BLACKWELL
DOI: 10.1002/hon.2208
Keywords
multiple myeloma; 17p deletion; intracranial myeloma; bortezomib consolidation
Categories
Ask authors/readers for more resources
In multiple myeloma (MM), del(17p) is associated with a poor outcome if present in greater than half the tumour cells. Similarly, intracranial involvement, often seen in the context of advanced disease, also heralds short survival. We present a rare case of MM presenting with intracranial disease and carrying del(17p) in 100% of tumour cells. This patient was successfully treated with combination chemotherapy employing central nervous system directed agents and bortezomib, followed by autologous stem cell transplant and consolidation with radiotherapy, bortezomib and thalidomide. We also present the outcomes of our single-centre experience ofMMpatients presenting with del(17p) disease. Copyright (C) 2015 John Wiley& Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available